Pacific Bio (PACB) Misses Q1 EPS by 1c, Miss on Revenues

Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.20), $0.01 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $19.4 million versus the consensus estimate of $24.54 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• BlackBerry shares gain premarket as Q2 results, guidance beat estimates
• H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance